ORZEYFUL™ available exclusively through Accredo

ORZEYFUL™ available exclusively through Accredo

A new FDA-approved treatment for adults with narcolepsy type 1

ORZEYFUL (oveporexton) is a first-in-class medication to treat narcolepsy type 1

As the exclusive specialty pharmacy for ORZEYFUL, Accredo® Specialty Pharmacy supports providers and patients throughout the specialty therapy journey, from referral and onboarding through ongoing treatment support.

Doctor speaking to patient
Accredo can fill your ORZEYFUL referrals

As the exclusive specialty pharmacy for ORZEYFUL, Accredo helps your patients start therapy sooner with coordinated support for providers, practice teams, and patients throughout the treatment journey.

Support throughout the therapy journey

Simplified access and coordination

Accredo provides coordinated support to reduce delays and administrative complexity, helping your practice navigate specialty pharmacy requirements and keep patients moving toward therapy.

Visibility that keeps your practice informed

Stay connected to your patients' specialty therapy journey with timely information and support from Accredo.

Ongoing support for your patients

Patients receive education, outreach, and personalized support to help them navigate questions and challenges throughout treatment.

Ready to refer a patient to Accredo?

Access provider resources, learn ways to submit your ORZEYFUL referral or manage your patients on the My Accredo Patients portal.

Doctor looking at laptop

Want additional information about ORZEYFUL?

Connect with our team for additional information.